Clinical Trial Update: Glucagon-like Peptide (GLP) Utilization and Safety

View source ↗

Summary

This clinical trial update reports completion of a study evaluating the use and safety of glucagon-like peptide therapies in Type 2 diabetes. The sponsor listed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: GlaxoSmithKline | Conditions: Diabetes Mellitus, Type 2 | Status: COMPLETED